fluconazole has been researched along with Leukemia L 1210 in 1 studies
Fluconazole: Triazole antifungal agent that is used to treat oropharyngeal CANDIDIASIS and cryptococcal MENINGITIS in AIDS.
fluconazole : A member of the class of triazoles that is propan-2-ol substituted at position 1 and 3 by 1H-1,2,4-triazol-1-yl groups and at position 2 by a 2,4-difluorophenyl group. It is an antifungal drug used for the treatment of mucosal candidiasis and for systemic infections including systemic candidiasis, coccidioidomycosis, and cryptococcosis.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Buchta, V | 1 |
| Pour, M | 1 |
| Kubanová, P | 1 |
| Silva, L | 1 |
| Votruba, I | 1 |
| Voprsálová, M | 1 |
| Schiller, R | 1 |
| Fáková, H | 1 |
| Spulák, M | 1 |
1 other study available for fluconazole and Leukemia L 1210
| Article | Year |
|---|---|
In vitro activities of 3-(halogenated phenyl)-5-acyloxymethyl- 2,5-dihydrofuran-2-ones against common and emerging yeasts and molds.
Topics: Animals; Antifungal Agents; Antineoplastic Agents; Drug Resistance, Fungal; Fluconazole; Fungi; Fura | 2004 |